The Korean Journal of Clinical Laboratory Science : eISSN 2288-1662 / pISSN 1738-3544

Table. 1.

Table. 1.

Status of manpower, number of tests, and screening tests by medical institutions

Category Type University hospital grade Hospital
grade
Commercial
lab
Average
Manpower status Pathologist 6.6 1.9 6.3
Pathological resident 4.3 1.0 0 
Cytotechnologist (KAC) 3.8 2.1 7.5
Cytotechnologist (IAC) 3.1 1.7 6.3
Total medical technologist 11.6 4.1 15.8
Screening performer 1.8 1.0 6.9
Number of tests Gynecology 12,447.5 8,541.1 270,292.1 62,198.5
Respiratory system 2,438.2 755.0 30,554.2 7,514.9
Body fluids 1,968.5 473.1 2,055.6 1,576.9
Urinary system 3,085.5 375.5 4,294.0 2,582.0
Thyroid gland 992.4 267.8 3,554.4 1,298.3
FNA 1,059.2 93.5 898.4 762.6
Number of 1st screening Minimum 1,462 477 200
Maximum 61,700 27,498 978,800
Average 20,738.4 9,707.2&nbspnbsp; 301,424.5
Percentage of the number of 1st screening Minimum 15 19 48
Maximum 100 100 100
Average 92.8 83.4 89.0
Primary screening work scope Gynecology 41 (100.0) 19 (95.0) 15 (100.0) 75 (98.7)
Respiratory system 38 (92.7) 8 (40.0) 9 (60.0) 55 (72.4)
Body fluids 38 (92.7) 7 (35.0) 4 (26.7) 49 (64.5)
Urinary system 37 (90.2) 8 (40.0) 6 (40.0) 51 (67.1)
Thyroid gland 26 (63.4) 4 (20.0) 2 (13.4) 32 (42.1)
FNA 26 (63.4) 3 (15.0) 1 (6.7) 30 (39.4)
Sample handling staff Cytotechnologist 11 (26.8) 7 (36.8) 0 (0.0)
MT 11 (26.8) 5 (26.3) 8 (53.3)
MT/KAC 19 (46.4) 7 (36.8) 5 (33.4)
Assistant 0 (0.0) 0 (0.0) 2 (13.3)
LBP user organization Gynecology 39 (100) 13 (100) 10 (100) 62 (100)
Respiratory system 36 (92.3) 6 (46.2) 3 (30.0) 45 (72.6)
Body fluids 35 (89.7) 6 (46.2) 2 (20.0) 43 (69.4)
Urinary system 35 (89.7) 6 (46.2) 2 (20.0) 43 (69.4)
Thyroid gland 23 (60.0) 4 (30.8) 1 (10.0) 28 (45.2)
FNA 21 (53.8) 3 (23.1) 1 (10.0) 25 (40.3)

*Primary screening work scope, sample handling staff, LBP user organization, N (%).

Abbreviations: MT, medical technologist; FNA, fine needle aspiration; LBP, liquid base preparation; KAC, korean association of cytotechnologists; IAC, international academy of cytotechnologists. N (%).

Korean J Clin Lab Sci 2021;53:174-87 https://doi.org/10.15324/kjcls.2021.53.2.174
© 2021 Korean J Clin Lab Sci